Progressive myoclonus epilepsy

Handbook of Clinical Neurology

Volumn 113, Issue , 2013, Pages 1731-1736

  Girard, Jean Marie ^a   Turnbull, Julie ^a   Ramachandran, Nivetha ^a   Minassian, Berge A ^a  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84876843804     PISSN: 00729752     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-444-59565-2.00043-5     Document Type: Chapter

References (38)

1. Andrade D.M., Ackerley C.A., Minett T.S., et al. Skin biopsy in Lafora disease: genotype-phenotype correlations and diagnostic pitfalls. Neurology 2003, 61:1611-1614.
2. Andrade D.M., del Campo J.M., Moro E., et al. Non-epileptic visual hallucinations in Lafora disease. Neurology 2005, 64:1311-1312.
3. Bassuk A.G., Wallace R.H., Buhr A.R., et al. A homozygous mutation in human PRICKLE1 causes an autosomal recessive progressive myoclonic epilepsy-ataxia syndrome. Am J Hum Genet 2008, 83:572-581.
4. Berkovic S.F., Mazarib A., Walid S., et al. A new clinical and molecular form of Unverricht-Lundborg disease localized by homozygosity mapping. Brain 2005, 128:652-658.
5. Bonten E.J., Arts W.F., Beck M., et al. Novel mutations in lysosomal neuraminidase identify functional domains and determine clinical severity in sialidosis. Hum Mol Genet 2000, 9:2715-2725.
6. Chan E.M., Young E.J., Ianzano L., et al. Mutations in NHLRC1 cause progressive myoclonus epilepsy. Nat Genet 2003, 35:125-127.
7. Chan E.M., Omer S., Ahmed M., et al. Progressive myoclonus epilepsy with polyglucosans (Lafora disease): evidence for a third locus. Neurology 2004, 63:565-567.
8. Chen C.M., Lai S.C., Chen I.C., et al. First report of two Taiwanese siblings with sialidosis type I: a 10-year follow-up study. J Neurol Sci 2006, 247:65-69.
9. Cavanagh J.B. Corpora-amylacea and the family of polyglucosan diseases. Brain Res Brain Res Rev 1999, 29:265-295.
10. El-Shanti H., Daoud A., Sadoon A.A., et al. A distinct autosomal recessive ataxia maps to chromosome 12 in an inbred family from Jordan. Brain Dev 2006, 28:353-357.
11. Filocamo M., Mazzotti R., Stroppiano M., et al. Early visual seizures and progressive myoclonus epilepsy in neuronopathic Gaucher disease due to a rare compound heterozygosity (N188S/S107L). Epilepsia 2004, 45:1154-1157.
12. Gentry M.S., Dowen R.H., Worby C.A., et al. The phosphatase laforin crosses evolutionary boundaries and links carbohydrate metabolism to neuronal disease. J Cell Biol 2007, 178:477-488.
13. Ianzano L., Zhang J., Chan E.M., et al. Lafora progressive Myoclonus Epilepsy mutation database-EPM2A and NHLRC1 (EPM2B) genes. Hum Mutat 2005, 26:397.
14. Joensuu T., Lehesjoki A.E., Kopra O. Molecular background of EPM1-Unverricht-Lundborg disease. Epilepsia 2008, 49:557-563.
15. Kalviainen R., Khyuppenen J., Koskenkorva P., et al. Clinical picture of EPM1-Unverricht-Lundborg disease. Epilepsia 2008, 49:549-556.
16. Lafora G.R. Uber das vorkommen amyloider korperchen im innern der ganglienzellen: zugleich en beitrag zum stadium der amyloiden substanz im nervensystem. Virchows Arch Pathol Anat Physiol Klin Med 1911, 205:295-303.
17. Lehtinen M.K., Tegelberg S., Schipper H., et al. Cystatin B deficiency sensitizes neurons to oxidative stress in progressive myoclonus epilepsy, EPM1. J Neurosci 2009, 29:5910-5915.
18. Lohi H., Ianzano L., Zhao X.C., et al. Novel glycogen synthase kinase 3 and ubiquitination pathways in progressive myoclonus epilepsy. Hum Mol Genet 2005, 14:2727-2736.
19. Lossos A., Meiner Z., Barash V., et al. Adult polyglucosan body disease in Ashkenazi Jewish patients carrying the Tyr329Ser mutation in the glycogen-branching enzyme gene. Ann Neurol 1998, 44:867-872.
20. Lundborg H. Die progressive Myoklonus-Epilepsie (Unverricht's Myoklonie) 1903, Almqvist und Wiksell's Buchdruckerei-A-G, Uppsala.
21. Magaudda A., Ferlazzo E., Nguyen V.H., et al. Unverricht-Lundborg disease, a condition with self-limited progression: long-term follow-up of 20 patients. Epilepsia 2006, 47:860-866.
22. Minassian B.A. Lafora's disease: towards a clinical, pathologic, and molecular synthesis. Pediatr Neurol 2001, 25:21-29.
23. Minassian B.A., Lee J.R., Herbrick J.A., et al. Mutations in a gene encoding a novel protein tyrosine phosphatase cause progressive myoclonus epilepsy. Nat Genet 1998, 20:171-174.
24. Nanduri A.S., Kaushal N., Clusman H., et al. The maestro don Gonzalo Rodriguez-Lafora. Epilepsia 2008, 49:943-947.
25. Pennacchio L.A., Lehesjoki A.E., Stone N.E., et al. Mutations in the gene encoding cystatin B in progressive myoclonus epilepsy (EPM1). Science 1996, 271:1731-1734.
26. Puschmann A. Unverricht-Lundborg disease - a misnomer?. Mov Disord 2008, 24:629-630.
27. Robitaille Y., Carpenter S., Karpati G., et al. A distinct form of adult polyglucosan body disease with massive involvement of central and peripheral neuronal processes and astrocytes: a report of four cases and a review of the occurrence of polyglucosan bodies in other conditions such as Lafora's disease and normal ageing. Brain 1980, 103:315-336.
28. Santoshkumar B., Turnbull J., Minassian B.A. Unverricht-Lundborg progressive myoclonus epilepsy in Oman. Pediatr Neurol 2008, 38:252-255.
29. Singh S., Satishchandra P., Shankar S.K., et al. Lafora disease in the Indian population: EPM2A and NHLRC1 gene mutations and their impact on subcellular localization of laforin and malin. Hum Mutat 2008, 29:E1-E12.
30. Straussberg R., Basel-Vanagaite L., Kivity S., et al. An autosomal recessive cerebellar ataxia syndrome with upward gaze palsy, neuropathy, and seizures. Neurology 2005, 64:142-144.
31. Striano P., Zara F., Turnbull J., et al. Typical progression of myoclonic epilepsy of the Lafora type: a case report. Nat Clin Pract Neurol 2008, 4:106-111.
32. Tagliabracci V.S., Girard J.M., Segvich D., et al. Abnormal metabolism of glycogen phosphate as a cause for Lafora disease. J Biol Chem 2009, 283:33816-33825.
33. Turk V., Bode W. The cystatins: protein inhibitors of cysteine proteinases. FEBS Lett 1991, 285:213-219.
34. Unverricht H. Die Myoclonie 1891, Leipzig and Vienna, Franz Deuticke.
35. Van Heycop Ten Ham M. Lafora disease, a form of progressive myoclonus epilepsy. The Epilepsies. Handbook of Clinical Neurology 1975, vol. 15:382-422. Elsevier, Amsterdam. P.J. Vinken, G.W. Bruyn (Eds.).
36. Vilchez D., Ros S., Cifuentes D., et al. Mechanism suppressing glycogen synthesis in neurons and its demise in progressive myoclonus epilepsy. Nat Neurosci 2007, 10:1407-1413.
37. Virtaneva K., D'Amato E., Miao J., et al. Unstable minisatellite expansion causing recessively inherited myoclonus epilepsy, EPM1. Nat Genet 1997, 15:393-396.
38. Yamada M., Shimohata M., Sato T., et al. Polyglutamine disease: recent advances in the neuropathology of dentatorubral-pallidoluysian atrophy. Neuropathology 2006, 26:346-351.